易方达医药生物股票C(010388)资产配置 |
|
|
| 报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
| 2026/3/31 |
2,851,660,000 |
- |
3,227,560,000 |
3,134,860,000 |
91% |
| 2025/12/31 |
2,754,470,000 |
- |
3,051,350,000 |
2,971,210,000 |
93% |
| 2025/9/30 |
3,331,340,000 |
- |
3,719,960,000 |
3,581,380,000 |
93% |
| 2025/6/30 |
2,817,170,000 |
- |
3,175,570,000 |
3,062,880,000 |
92% |
| 2025/3/31 |
3,605,190,000 |
- |
3,942,980,000 |
3,808,680,000 |
95% |
| 2024/12/31 |
2,911,750,000 |
- |
3,305,330,000 |
3,126,190,000 |
93% |
| 2024/9/30 |
3,812,140,000 |
- |
4,119,000,000 |
4,084,600,000 |
93% |
| 2024/6/30 |
2,870,870,000 |
3,210,740 |
3,139,510,000 |
3,122,790,000 |
92% |
| 2024/3/31 |
3,057,050,000 |
2,331,440 |
3,324,160,000 |
3,300,450,000 |
93% |
| 2023/12/31 |
3,439,200,000 |
1,735,110 |
3,682,270,000 |
3,649,680,000 |
94% |
| 2023/9/30 |
2,602,480,000 |
1,579,750 |
2,879,360,000 |
2,851,610,000 |
91% |
| 2023/6/30 |
2,519,480,000 |
1,614,980 |
2,715,910,000 |
2,698,790,000 |
93% |
| 2023/3/31 |
2,690,340,000 |
1,639,020 |
2,905,310,000 |
2,884,810,000 |
93% |
| 2022/12/31 |
2,463,830,000 |
1,657,410 |
2,710,380,000 |
2,681,590,000 |
92% |
| 2022/9/30 |
1,784,170,000 |
1,579,600 |
2,118,040,000 |
2,109,250,000 |
85% |
| 2022/6/30 |
2,092,770,000 |
1,595,040 |
2,431,360,000 |
2,406,850,000 |
87% |
| 2022/3/31 |
1,879,230,000 |
1,432,360 |
2,278,870,000 |
2,250,940,000 |
83% |
| 2021/12/31 |
2,113,130,000 |
1,629,760 |
2,626,780,000 |
2,618,910,000 |
81% |
| 2021/9/30 |
2,308,390,000 |
1,473,150 |
2,756,310,000 |
2,743,020,000 |
84% |
| 2021/6/30 |
2,908,920,000 |
1,572,060 |
3,288,320,000 |
3,082,390,000 |
94% |
| 2021/3/31 |
2,625,290,000 |
1,518,580 |
3,818,070,000 |
3,790,460,000 |
69% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
